Scopio's suite of digital Full-Field™ imaging and AI-powered Decision Support platforms. The X100 (left) and the X100HT (right) cater to hospitals and lab networks of all sizes, offering fully remote review capabilities for real-time diagnosis and improved clinical decision making.

Exciting news for Scopio Labs

We are excited to share some very important milestones, that Scopio Labs was able to reach in recent weeks:

1. FDA Clearance for High Throughput Hematology Digital Cell Morphology Platform, Replacing Microscopes with Digitization

Read the full announcement here:

https://www.prnewswire.com/il/news-releases/scopio-labs-awarded-fda-clearance-for-high-throughput-hematology-digital-cell-morphology-platform-replacing-microscopes-with-digitization-301564972.html

2. Beckman Coulter and Scopio Labs Partner to Accelerate Adoption of Hematology Digital Cell Morphology Platform

We are excited to share that Beckman Coulter and Scopio Labs have entered into a worldwide distribution partnership. “It is an honor to partner with Beckman Coulter, the pioneers of automated hematology testing and a known industry innovator, to accelerate the digital transformation of hematology laboratories worldwide. By introducing digitalization to Peripheral Blood Smear review at scale, Scopio completes a crucial piece of the puzzle.”

Itai Hayut, CEO, Scopio Labs:

“I cannot be more thrilled to announce that we have partnered with Beckman Coulter, a global leader in laboratory diagnostics, to bring Scopio Labs’ full-field cell morphology platforms to hematology labs worldwide!
Our imaging and AI-powered Peripheral Blood Smear analysis technology is catalyzing a complete digital transformation for our customers, and this partnership will accelerate the transition of the field to a powerful data-driven, digital, and AI-assisted workflow.“

Read the full announcement here:

https://www.prnewswire.com/news-releases/beckman-coulter-and-scopio-labs-partner-to-accelerate-adoption-of-hematology-digital-cell-morphology-platform-301590030.html

Aescuvest enables great health innovations through equity investments. It is the leading platform to foster and fund smart healthcare ideas. This independent launch pad offers financing strategies to companies & an above-average profit share to investors.

EIT Health is one of the largest healthcare initatives wordwide. Its goal is to sustainably advance the fundamentals of healthcare and thus promote suitable future conditions for healthy living, active ageing and improved wellbeing of people across Europe.

About us

For Investors

For idea providers

Help & legal

Stay tuned

Follow us on

Subscribe to our newsletter

By clicking on ‘Sign up’, you agree to receive the newsletter with information on, for example, our services, our company as well as to its analysis through individual measurement, storage and evaluation of opening rates and click rates in recipient profiles for the purpose of designing future newsletters according to the interests of our readers. Consent can be revoked with effect for the future. Detailed information is available in our data privacy terms.